A detailed history of Bank Of America Corp transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 156 shares of MAIA stock, worth $344. This represents 0.0% of its overall portfolio holdings.

Number of Shares
156
Previous 137 13.87%
Holding current value
$344
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.54 - $3.87 $48 - $73
19 Added 13.87%
156 $0
Q2 2024

Aug 14, 2024

BUY
$1.96 - $5.1 $268 - $698
137 New
137 $0
Q4 2023

Feb 14, 2024

BUY
$0.83 - $2.54 $6 - $20
8 New
8 $0
Q4 2022

Feb 10, 2023

BUY
$3.1 - $3.85 $6 - $7
2 New
2 $0

Others Institutions Holding MAIA

About MAIA Biotechnology, Inc.


  • Ticker MAIA
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,935,900
  • Market Cap $24.2M
  • Description
  • MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...
More about MAIA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.